Skip to content
Starco Replay

Zimbabwe Rejects ‘Lopsided’ American Healthcare Assistance Agreement Over Data Fears

Health funding illustration
The offered US financial assistance was intended for programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has rejected a major American health deal worth $367m (272 million pounds) over five years because of Washington's demand for confidential biological samples.

The decision became public after a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "skewed".

An official representative later explained that the United States was demanding access to genetic material for research and profit but refused to share the benefits from future treatments.

"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.

A medical body in Zimbabwe has called for further negotiations to find a deal suitable to both sides so the country's vital HIV programme can be sustained.

Broader Background

This development comes after a similar case in neighbouring Kenya, where a high court suspended a similar deal with the US following concerns were raised about the security of Kenyans' medical information.

After returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

USAID had administered aid for the US government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance transparency and accountability.

According to statements, 16 nations in Africa have to date signed these new health pacts, representing over $18.3bn in new funding.

Specifics of the Declined Deal

The funds for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this partnership could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million currently on antiretroviral therapy via US-supported programmes," the Ambassador said.

However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".

"Our nation was requested to surrender its biological resources and data over an extended period, without any equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," his statement read.

"Put simply, our country would supply the basic resources for scientific discovery with no assurance that the end products would be accessible to our people should a future pandemic arise."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining systems previously set up through the international health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.

"This mechanism is designed to ensure that when a country contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."

Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," he added.

"We are open to continued discussions with our American counterparts on how future co-operation could be arranged in a way that honours the sovereignty and dignity of each country."

Health Experts Reaction

A leading public health body said it understood the official position, but suggested that talks need to persist given that much of the nation's HIV programmes were funded by external financing.

"In cases where technical issues exist, such as those involving data governance or agreement terms, these can often be resolved through technical clarification and negotiated safeguards," it said.

The halted deal underscores the complex challenges between receiving much-needed foreign assistance and safeguarding a country's data in an ever more data-driven world.

KR
By

Katherine Roberts

A lifelong retro gaming enthusiast and collector, specializing in 80s and 90s console history and game preservation.

Starco Replay

Type to search articles.